Ghrelin: Clinical Trials

31 trials of Ghrelin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 3 unknown, 1 recruiting, 1 terminated. 10 Not applicable, 10 Phase 1, 10 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 8, Unknown 2
Phase 110Completed 9, Withdrawn 1
Phase 210Completed 8, Recruiting 1, Unknown 1
Early Phase 11Completed 1
Phase 31Completed 1

Follow Ghrelin: new trials by email Literature Review of Ghrelin trials Research Report on Ghrelin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Tesamorelin, Placebo, Exercise - HIV-1-infection, Frailty
Phase 2RecruitingMassachusetts General Hospital1002025-07-102026-05-19
Effects of Ghrelin Administration on Motivation
Ghrelin, Saline - Major Depressive Disorder
Not applicableCompletedUniversity Hospital Tuebingen242024-09-022025-12-22
RCT of Ghrelin in Stroke Patients
Ghrelin - Stroke, Ischemic
Phase 2UnknownRijnstate Hospital802023-10-012023-07-25
Effects of Ghrelin Administration on Dopamine and Effort
Ghrelin, Placebo - Major Depressive Disorder
Phase 1 / Phase 2CompletedUniversity Hospital Tuebingen262022-02-212025-12-22
The Importance of Ghrelin for Glucose Metabolism After Sleeve Gastrectomy
Ghrelin, Placebo - Bariatric Surgery Candidate, Glucose Metabolism Disorders
Not applicableCompletedHvidovre University Hospital222022-01-142023-11-01
Ghrelin (OXE--103) for Acute Concussion Management
Ghrelin (OXE-103), Placebo - Concussion, Brain, Traumatic Brain Injury
Phase 2CompletedMichael Rippee232020-10-202024-05-21
Unacylated Ghrelin to Improve Functioning in PAD
Ghrelin, Placebo - Peripheral Artery Disease
Phase 2CompletedNorthwestern University252020-07-082026-06-01
Physiological Responses to Laparoscopic Sleeve Gastrectomy: Focusing on Ghrelin
Placebo, Ghrelin - Bariatric Surgery
Not applicableCompletedHvidovre University Hospital122020-02-282024-02-28
Effect of Ghrelin on Decision-Making
Ghrelin, Saline - Healthy Volunteers, Obesity
Phase 1WithdrawnJenny Tong, MD, MPH2019-10-012020-01-27
Nutrition and Growth in Very Preterm Infants
Oral nutritional intake - Premature, Growth
CompletedChildren's Hospital of Fudan University1802019-08-012023-02-08
Influence of Dairy Protein Breakfast on Glycemia, Weight Loss and Clock Genes in T2D
Continuous glucose monitoring CGM, Clock Genes m RNA expression, Postprandial Glucose - Type2 Diabetes, Healthy Obesity, Metabolically
Not applicableUnknownTel Aviv University602018-12-282018-12-11
Validation of the Concept of the Autoantibodies Directed Against the Neuropeptides Involved in Food Intake Regulation on the Incidental Cases of Eating Disorders
Evaluation of the rates of the autoantibodies directed against the neuropeptides (ghrelin and alpha-MSH) controlling involved in food intake regulation - Eating Disorder
Not applicableCompletedUniversity Hospital, Rouen2112018-05-242026-02-06
Ghrelintrial With Patients With Stroke
Ghrelin - DEMMMI, Nine-Hole-PEG-Test, mRS, Stroke, Acute
TerminatedKantonsspital Winterthur KSW62017-04-012019-03-01
Preprandial Ghrelin Effect
Ghrelin, Saline - Type 2 Diabetes
Phase 1CompletedJenny Tong, MD, MPH802017-01-112019-03-12
Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline - Obesity
Phase 1CompletedVanderbilt University Medical Center702016-09-012023-02-08
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women
IM Saline Placebo (0.25 ml), IM Estradiol valerate (2.5 mg), IM Saline Placebo (0.5 ml) - Healthy
Phase 1CompletedMayo Clinic472014-12-012018-03-22
Ghrelin Plus Strength Training in Frail Elderly Study
Ghrelin, Placebo - Frailty Syndrome
Phase 2CompletedUniversity of Pennsylvania162013-07-012019-12-11
Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure
Ghrelin, Placebo - Heart Failure With Reduced Ejection Fraction HFrEF
Phase 1 / Phase 2CompletedLars Lund312013-02-172024-10-23
Ghrelin Repeated Dose Study
ghrelin - Frailty in Aging
Phase 2CompletedUniversity of Pennsylvania52013-02-012015-10-08
Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers
Ghrelin, Placebo, fMRI - fMRI, Alcohol Drinking
Phase 2CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)172012-12-132018-08-03

Showing 20 of 31. Sign in to see all of them.

Conditions studied

Obesity (4)  ·  Depressive Disorder, Major (3)  ·  Alcoholism (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Frailty (2)  ·  Alcohol Drinking (1)  ·  Anhedonia (1)  ·  Behavior, Addictive (1)  ·  Body Weight (1)  ·  Brain Concussion (1)  ·  Brain Injuries, Traumatic (1)  ·  Cachexia (1)  ·  Cystic Fibrosis (1)  ·  Feeding and Eating Disorders (1)  ·  Glucose Metabolism Disorders (1)

Sponsors

University of Aarhus (3)  ·  Hvidovre University Hospital (2)  ·  Jenny Tong, MD, MPH (2)  ·  University Hospital Tuebingen (2)  ·  University of Pennsylvania (2)  ·  Baker Heart and Diabetes Institute (1)  ·  Brown University (1)  ·  Cantonal Hospital of St. Gallen (1)  ·  Children's Hospital of Fudan University (1)  ·  Esben Thyssen Vestergaard (1)  ·  Göteborg University (1)  ·  Kantonsspital Winterthur KSW (1)  ·  Lars Lund (1)  ·  Massachusetts General Hospital (1)  ·  Max-Planck-Institute of Psychiatry (1)

Countries

United States (12)  ·  Denmark (5)  ·  Germany (3)  ·  Switzerland (2)  ·  Australia (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Anne Cappola, MD, ScM (1)  ·  Anne R. Cappola, M.D.,Sc.M. (1)  ·  Esben T Vestergaard, PhD (1)  ·  Esben T. Vestergaard, MD PhD (1)  ·  Florian Strasser, PD Dr. MD (1)  ·  Jenny Tong, MD (1)  ·  Jenny Tong, MD, MPH (1)  ·  Jens Otto L. Jorgensen, MD (1)  ·  Kent Lundholm, MD, prof (1)  ·  Kristine M. Erlandson, MD (1)  ·  Lindsay T. Fourman, MD (1)  ·  Lorenzo Leggio, M.D. (1)  ·  Mary McDermott, MD (1)  ·  Michael Rippee, MD (1)

Results publications

PMID 22259063, PMID 23592479, PMID 24775991, PMID 28736944, PMID 29133954, PMID 31608930, PMID 35724307, PMID 36588397, PMID 36916707, PMID 41329966, PMID 41546024, PMID 41578008, PMID 42224086, PMID 42419889

NIH funding

R01DK091748 (2), R01DK097550 (1), R21AG063076 (1)